cfDNA test
- Application of calculating cell-free fetal DNA concentration with the fragment length difference in multiple gestations
- Cell-free DNA testing in twins: application in a tertiary private University Hospital.
- CfDNA testing and risk of fetal aneuploidy in cases with failed results due to low fetal fraction
- Characteristics of women choosing cf-DNA testing in screening for aneuploidies
- Comparison of different characteristics of IVF and non-IVF patients who have opted for the NIPT
- Does cfDNA testing change the spectrum of detected major chromosomal aberrations?
- How NIPT test has changed the prenatal screening in The Ixelles Hospitals form 2010 to 2015
- Implications of fetoplacental mosaicism on cell-free DNA testing for sex chromosome aneuploidies
- Non invasive prenatal test for duchenne muscular dystrophy
- Non-invasive prenatal testing for aneuploidies - a single center experience
- Non-invasive prenatal tests: impact on a group of Portuguese population
- Noninvasive prenatal testing for fetal trisomies in a routine first-trimester screening setting
- Our experience in applying non-invasive prenatal testing
- Performance of non-invasive prenatal test in India
- Positive testing for trisomy 13 and 18 using cfDNA
- Prenatal screening for 22q11.2 deletions using a targeted microarray - based cell - free (cfDNA) test
- Prospective validation study of the detection rate of Trisomy test for the common trisomies
- Screening strategies for the detection of all fetal karyotype abnormalities
- Single- nucleotide polymorphism-based non-invasive prenatal screening for fetal aneuploidies
- The clinical utility of genome-wide non-invasive prenatal screening
- Use of maternal age or first trimester screening risk in the estimation of trisomy risk in cfDNA screening test